Tian An Medicare Limited (HKEX: 383) has issued a notice of Special General Meeting (SGM) to be held on Monday, 18 May 2026, at 11:30 a.m. (or immediately after the annual general meeting scheduled for the same day) at Novotel Century Hong Kong. The primary agenda is to seek shareholder approval for a conditional cash offer to buy-back up to 70,000,000 shares at HK\$1.1 per share.

Key Points Investors Need to Know

• Buy-Back Offer: The company, through Morton Securities Limited, proposes to buy-back up to 70 million ordinary shares (nominal value HK\$0.01 each) at HK\$1.1 per share.
• Offer Documentation: The full terms and conditions are detailed in the offer document sent to shareholders on 28 April 2026. The form of acceptance must be duly completed as per instructions.
• Authority: The buy-back is in addition to any existing general mandate previously granted to the Board to repurchase shares. Directors will be authorized to execute all necessary documents and actions to effect the buy-back, including affixing the company seal as required.
• Voting Method: The resolution will be decided by poll, as required by HKEX Listing Rules. Results will be published on the HKEX and company websites.
• Proxy Arrangements: Shareholders entitled to attend can appoint one or more proxies, who need not be members of the company. Proxies must be lodged at Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or via the designated e-voting URL, no less than 48 hours before the meeting.
• Record Date and Book Closure: The register of members will be closed from 13 May 2026 to 18 May 2026 (both days inclusive). To be eligible to attend and vote, shareholders must ensure all share transfers are lodged by 4:30 p.m. on 12 May 2026.
• Board Composition: The Board consists of two Executive Directors (Mr. Kong Muk Yin and Mr. Guo Meibao), five Non-Executive Directors (including Chairman Mr. Lee Seng Hui), and four Independent Non-Executive Directors.

Potential Share Price Impact and Shareholder Considerations

• Price Sensitivity: The offer price of HK\$1.1 per share represents a direct cash return to shareholders who tender their shares. The buy-back could provide short-term price support and may be interpreted as a signal of undervaluation or excess capital, both factors that can influence the share price.
• Shareholder Value: A significant reduction in outstanding shares (up to 70 million) may enhance per-share metrics such as EPS, potentially benefiting remaining shareholders if the buy-back is completed.
• Action Required: Shareholders need to review the offer document and, if they wish to participate in the buy-back, must complete and return the form of acceptance before the stated deadline.
• Voting Rights: Shareholders should also consider voting at the SGM either in person or by proxy to express their view on the proposed buy-back.

Important Deadlines

• Last Day to Register Transfers: 12 May 2026, 4:30 p.m.
• Book Closure Period: 13 May 2026 – 18 May 2026
• Special General Meeting: 18 May 2026, 11:30 a.m.
• Proxy Submission Deadline: At least 48 hours before the SGM

Conclusion

The proposed conditional cash offer to buy-back shares by Tian An Medicare Limited is a significant corporate action that could influence the company’s share price and capital structure. Shareholders are strongly advised to review the offer document, consider the potential benefits and risks, and participate in the SGM to have their say on this important resolution.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should refer to the official company documents and seek professional advice before making any investment decisions. The forthcoming buy-back offer and related SGM approval may impact Tian An Medicare Limited’s share price and investor returns.

View TIANAN MEDICARE Historical chart here